시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 이식 진단 시장 : 규모, 점유율, 성장 분석, 기술별, 제품 및 서비스별, 용도별, 이식 유형별, 최종 사용자별, 지역별 산업 예측(2024-2031년)
Transplant Diagnostics Market Size, Share, Growth Analysis, By Technology (Molecular Assay Technologies, Pcr-Based Molecular Assays), By Product & Services, By Application, By Transplant Type, By End User, By Region - Industry Forecast 2024-2031
상품코드 : 1619085
리서치사 : SkyQuest
발행일 : 2024년 12월
페이지 정보 : 영문 157 Pages
 라이선스 & 가격 (부가세 별도)
US $ 5,300 ￦ 7,590,000
PDF & Excel (Single User License) help
PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,200 ￦ 8,879,000
PDF & Excel (Multiple User License) help
PDF 및 Excel 보고서를 동일 사업장에서 2-5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,100 ￦ 10,168,000
PDF & Excel (Enterprise License) help
PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

이식진단의 세계 시장 규모는 2022년 43억 달러로 평가되었으며, 2023년 46억 2,000만 달러에서 2031년에는 82억 4,000만 달러로 성장해 예측기간(2024-2031년) CAGR 7.5%로 나타날 전망입니다.

세계의 이식진단시장은 장기이식 수요의 높아짐, 진단기술의 진보, 장기부전으로 이어지는 만성질환의 만연 증가 등에 힘입어 강력한 성장을 이루고 있습니다. 환자의 결과와 성공률을 높이기 위해 필수적이고 정확하고 효율적인 이식 적합성 검사에 대한 중요한 요구에 의해 더욱 뒷받침됩니다. 인공지능(AI)과 머신러닝(ML)이 이식 진단에 통합되어 유전체 정보와 임상 정보를 포함한 방대한 데이터 세트의 분석이 가능하게 된 것입니다. 할당 최적화에 도움이 될 뿐만 아니라 진단의 정확성과 효율성이 크게 향상되고 궁극적으로 이식 수술에서 환자 결과와 리소스 활용도가 향상됩니다.

목차

소개

조사 방법

주요 요약

시장 역학과 전망

주요 시장 인사이트

이식진단 시장 규모 : 기술별 및 CAGR(2024-2031년)

이식진단 시장 규모 : 제품 및 서비스별 및 CAGR(2024-2031년)

이식진단 시장 규모 : 용도별 및 CAGR(2024-2031년)

이식진단 시장 규모 : 이식유형별 및 CAGR(2024-2031년)

이식 진단 시장 규모 : 최종 사용자별 및 CAGR(2024-2031년)

이식 진단 시장 규모 및 CAGR(2024-2031년)

경쟁 정보

주요 기업 프로파일

결론과 권장사항

JHS
영문 목차

영문목차

Global Transplant Diagnostics Market size was valued at USD 4.3 billion in 2022 and is poised to grow from USD 4.62 billion in 2023 to USD 8.24 billion by 2031, growing at a CAGR of 7.5% during the forecast period (2024-2031).

The global transplant diagnostics market is experiencing robust growth, fueled by rising organ transplantation demands, advancements in diagnostic technologies, and increasing chronic disease prevalence leading to organ failure. This market expansion is further supported by a critical need for precise and efficient transplant compatibility testing, essential for enhancing patient outcomes and success rates. A notable trend is the integration of artificial intelligence (AI) and machine learning (ML) into transplant diagnostics, enabling the analysis of vast datasets, including genomic and clinical information. These advanced technologies not only help identify compatibility patterns and optimize organ allocation but also significantly enhance the accuracy and efficiency of diagnostics, ultimately improving patient outcomes and resource utilization in transplant procedures.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Transplant Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Transplant Diagnostics Market Segmental Analysis

Global Transplant Diagnostics Market is segmented by technology, product & services, application, transplant type, end user and region. Based on technology, the market is segmented into molecular assay technologies, sequencing based molecular assays and non molecular assays technologies. Based on product, the market is segmented into reagents & consumables, instruments and software & services. Based on application, the market is segmented into diagnostic application and research applications. Based on transplant type, the market is segmented into solid organ transplantation, stem cell transplantation, soft tissue transplantation and bone marrow transplantation. Based on end user, the market is segmented into hospitals and transplant centers, research & academic institutes and independent reference laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Transplant Diagnostics Market

The Global Transplant Diagnostics market is primarily driven by the rising demand for organ transplantation procedures, largely influenced by the increasing prevalence of chronic conditions like end-stage renal disease, heart failure, and liver cirrhosis. As more patients seek effective treatments to enhance their quality of life, the recognition of organ transplantation's benefits is becoming widespread among both patients and healthcare providers. This growing awareness necessitates precise and efficient compatibility testing between donors and recipients, thereby propelling the expansion of the transplant diagnostics sector. Enhanced diagnostic methods are critical in ensuring successful transplant outcomes, further stimulating market growth.

Restraints in the Global Transplant Diagnostics Market

The Global Transplant Diagnostics market faces significant challenges due to the critical shortage of organ donors. The overwhelming demand for organ transplants surpasses the supply of suitable organs, resulting in extensive waiting lists for patients. This situation not only heightens the risk of mortality and disease advancement during these waiting periods but also hampers the performance of transplant diagnostic procedures. Consequently, the limited organ availability constrains the market potential for diagnostic products and services. Furthermore, ethical dilemmas, legal regulations, and cultural obstacles surrounding organ donation in various regions exacerbate this shortage, further restricting growth opportunities within the transplant diagnostics sector.

Market Trends of the Global Transplant Diagnostics Market

A prominent trend in the global transplant diagnostics market is the rising integration of next-generation sequencing (NGS) technology, which is transforming the landscape of organ transplantation. NGS enables comprehensive genetic profiling of both donors and recipients, significantly enhancing the matching process through detailed analysis of the human leukocyte antigen (HLA) system and other critical genetic markers. This cutting-edge approach surpasses traditional methods by accommodating a broader spectrum of HLA alleles, unveiling rare variants, and enabling the simultaneous evaluation of multiple genetic indicators. As such, NGS not only streamlines the diagnostic workflow but also holds the potential to substantially improve transplant success rates and patient outcomes through optimized donor-recipient compatibility.

Table of Contents

Introduction

Research Methodology

Executive Summary

Market Dynamics & Outlook

Key Market Insights

Global Transplant Diagnostics Market Size by Technology & CAGR (2024-2031)

Global Transplant Diagnostics Market Size by Product & Service & CAGR (2024-2031)

Global Transplant Diagnostics Market Size by Application & CAGR (2024-2031)

Global Transplant Diagnostics Market Size by Transplant Type & CAGR (2024-2031)

Global Transplant Diagnostics Market Size by End User & CAGR (2024-2031)

Global Transplant Diagnostics Market Size & CAGR (2024-2031)

Competitive Intelligence

Key Company Profiles

Conclusion & Recommendations

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기